Fachliteratur Gastroenterologie: Leber

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber

07. Mai 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 12748


	Artikel 1 - 20 / 254942

	Unraveling the pleiotropic effects of CCR2-dependent signal transduction in fibrosis development. Theranostics Sun G, Wang J, Tang J, Chen M, Zhang Z, Zhao H, Jin Z, Xu X, Yang Y, Liu J. PMID: 42094612 [PubMed - indexed for MEDLINE]
	Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinoma. Theranostics Yilmaz EY, Schmidt R, Heidemann L, He Y, Liu Y, Sulejmani O, Müller DN, Wilhelm A, Auer TA, Hamm CA, Abosabie SAS, Abosabie SA, Gebauer B, Savic LJ. PMID: 42094598 [PubMed - indexed for MEDLINE]
	Clinical Setting Modulates the Association Between Genetic Variants and Fibrosis Severity Across the Spectrum of MASLD. Liver Int Lee MH, Stepanova M, Estep M, You YL, Liu XR, de Avila L, Lam B, Yu ML, Younossi ZM. PMID: 42093660 [PubMed - indexed for MEDLINE]
	Faecal Cathepsin B and S Are Associated With Liver Disease Severity and Adiposity in MASLD. Liver Int Harberts A, Fondevila MF, Kreimeyer H, Miwa T, Lang S, Demir M, Schnabl B. PMID: 42093609 [PubMed - indexed for MEDLINE]
	Fenugreek seed extract-doxorubicin synergy against hepatocellular carcinoma in HepG2 cells: in vitro and in silico mechanistic studies. BMC Complement Med Ther Ragab W, Mahmoud K, Allam RM, Qayed WS, Gomaa OM, El-Hawary SS, Moawad AS, Mohammed R. PMID: 42092913 [PubMed - indexed for MEDLINE]
	Sintilimab (PD-1 inhibitor) plus lenvatinib as conversion therapy followed by sequential surgery (SILENSES) for advanced unresectable hepatocellular carcinoma: a phase II, expansion trial. Signal Transduct Target Ther Lu S, Zhang W, Li J, Zhang Z, Hu B, Li X, Cao Y, Wang Z, Wang Z, Ye H, Qu B, Li Y, Ma G, Wan T, Liu Z, Liu B, Xu Y, Tang H, Zhao X, Pan L, Yang L, Yuan J, Chen R, Bian X. PMID: 42091859 [PubMed - indexed for MEDLINE]
	The Dual Role of Saikosaponins in Liver Disease Treatment: A Comprehensive Review of Pharmacological Activities and Toxicological Characteristics. Biol Pharm Bull Zhu S, Hao D, Mao B, Hua Y, Wang B, Wang P, Yuan W. PMID: 42091451 [PubMed - indexed for MEDLINE]
	Nutritional Risk Assessed by Royal Free Hospital-Nutritional Prioritizing Tool Predicts Survival in Cirrhosis With or Without Hepatocellular Carcinoma. J Korean Med Sci Park HJ, Jung JK, Noh J, Kim Y, Lee SU, Yun BC, Lee JW, Kim HJ, Seo KI. PMID: 42089136 [PubMed - indexed for MEDLINE]
	Integrated transcriptomic and single cell analysis combined with artificial neural network identifies a robust gene signature for early discrimination of MASL and MASH. Front Immunol Lin GW, Lin ZY, Su QY, Ye L, Xu WN, Nong SQ, Wu RK, Zhou WJ, Huang QF. PMID: 42088521 [PubMed - indexed for MEDLINE]
	Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver disease. Front Immunol Ángel-Gomis E, Juanola O, Caparrós E, Francés R. PMID: 42088501 [PubMed - indexed for MEDLINE]
	Exercise Impacts Liver Disease: Balancing Metabolic and Immune Homeostasis. Int J Biol Sci Cheng C, Xu W, Wu S, Gao J, Huang J, Dong Y, Ji J, Zuo L, Wang H. PMID: 42088433 [PubMed - indexed for MEDLINE]
	Research Progress on Nanoformulations Based on Active Components from Traditional Chinese Medicine for MASLD. Int J Nanomedicine Gou ZX, Li NW, Yao JY, Wang YL. PMID: 42088396 [PubMed - indexed for MEDLINE]
	Splenic Marginal Zone Lymphoma as a Vascular-Appearing Mass in a Patient With Sustained Virologic Response to Hepatitis C Therapy. Am J Case Rep Tan XHI, Yee HN, Kwan KWC, Tan AYH, Kok S, Tan MO. PMID: 42087428 [PubMed - indexed for MEDLINE]
	Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver Diseases. J Cachexia Sarcopenia Muscle Tanaka T, Suda G, Ohara M, Yokoyama D, Kitano S, Maehara O, Yoda T, Fu Q, Yang Z, Yasuura N, Meno A, Sasaki T, Kohya R, Kitagataya T, Kawagishi N, Nakai M, Sho T, Ohnishi S, Sakamoto N. PMID: 42087383 [PubMed - indexed for MEDLINE]
	Using the enhanced liver fibrosis test to identify disease in at-risk populations. BMJ Open Gastroenterol Hinkson A, Feathers J, Punnamkuzhy J, Dzhakangirli F, Rowe IA, Parker R. PMID: 42086293 [PubMed - indexed for MEDLINE]
	Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era. BMJ Open Gastroenterol Chen S, Shen L, Qi H, Hu P, Cao F, Xie L, Wang Y, Fan W. PMID: 42086291 [PubMed - indexed for MEDLINE]
	Comparison of Serum Prolactin Level with Child-Pugh Scoring System in Predicting the Complications of Cirrhosis of Liver: A Cross-sectional Study. Niger Postgrad Med J Kishor AR, Sandeep MLN, Reddy K, Kumar JS, Sethupathi SP. PMID: 42085053 [PubMed - indexed for MEDLINE]
	Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma. Radiology Berman ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, Sandow T, Gimenez J, Young S, Fidelman N, Pianka KT, Sher A, Alamuri T, Chan SM, Vakil P, Wang M, Abounorinejad F, Som A, Johnson GE, Padia SA, Kim E, Toskich BB. PMID: 42084516 [PubMed - indexed for MEDLINE]
	Diffusion-weighted Imaging of the Liver: Primed for New Business. Radiology Brunsing RL, Syed AB, Hargreaves BA, Ennis DB. PMID: 42084512 [PubMed - indexed for MEDLINE]
	Risk of Intrahepatic and Extrahepatic Cancers in HepatitisÂ C Virus Infection: A Nationwide Cohort Study in Korea, 2005-2023. Liver Int Park Y, Kim BW, Oh JK, Kim BH, Park SJ, Kim KA, Ki M. PMID: 42084000 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 254942

Seite 1 von 12748



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung